Technical Analysis for NVUS - Novus Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 2.16 0.47% 0.01
NVUS closed up 0.47 percent on Friday, January 18, 2019, on 27 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical NVUS trend table...

Date Alert Name Type % Chg
Jan 18 Wide Bands Range Expansion 0.00%
Jan 17 Narrow Range Bar Range Contraction 0.47%
Jan 17 Wide Bands Range Expansion 0.47%
Jan 16 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -5.26%
Jan 16 Narrow Range Bar Range Contraction -5.26%
Jan 16 NR7 Range Contraction -5.26%
Jan 16 NR7-2 Range Contraction -5.26%
Jan 16 Stochastic Reached Overbought Strength -5.26%
Jan 16 Weak + Overbought Other -5.26%
Jan 16 Inside Day Range Contraction -5.26%

Older signals for NVUS ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Novus Therapeutics, Inc., formerly Tokai Pharmaceuticals, Inc., is a pharmaceutical company. The Company is focused on the acquisition, development, and commercialization of ear, nose, and throat products. It has two platforms: OP-01 Foam Platform and OP-02 Surfactant Program. OP-01 is developed with the intent to be used as a delivery vehicle for drugs treating ears, as well as the nasal and sinus cavities. OP-01 is currently being developed as an improved treatment option for acute otitis externa. OP-02 is a daily nasal spray that is designed to improve and maintain a healthy middle ear. OP-02 is being developed as a potential treatment option for patients with otitis media and Eustachian tube dysfunction. OP-02 is a combination drug product, which comprises two components: surfactant dipalmitoylphosphatidylcholine and a spreading agent cholesteryl palmitate. The product is sprayed through the nostrils toward the opening of the Eustachian tube at the back of the nasal cavity.
Is NVUS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 8.61
52 Week Low 1.52
Average Volume 27,195
200-Day Moving Average 4.8063
50-Day Moving Average 2.9482
20-Day Moving Average 2.102
10-Day Moving Average 2.24
Average True Range 0.2856
ADX 27.34
+DI 15.2922
-DI 19.2979
Chandelier Exit (Long, 3 ATRs ) 2.2032
Chandelier Exit (Short, 3 ATRs ) 2.3768
Upper Bollinger Band 2.6862
Lower Bollinger Band 1.5178
Percent B (%b) 0.55
BandWidth 55.585157
MACD Line -0.1782
MACD Signal Line -0.2493
MACD Histogram 0.0712
Fundamentals Value
Market Cap 15 Million
Num Shares 6.94 Million
EPS -3.46
Price-to-Earnings (P/E) Ratio -0.62
Price-to-Sales 0.00
Price-to-Book 1.14
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.49
Resistance 3 (R3) 2.53 2.45 2.44
Resistance 2 (R2) 2.45 2.37 2.44 2.42
Resistance 1 (R1) 2.31 2.32 2.27 2.27 2.40
Pivot Point 2.23 2.23 2.22 2.22 2.23
Support 1 (S1) 2.09 2.15 2.05 2.05 1.92
Support 2 (S2) 2.01 2.10 2.00 1.90
Support 3 (S3) 1.87 2.01 1.89
Support 4 (S4) 1.83